Startup Vima Adds Parkinson’s to Movement Disorder Scope, Expanding Series A Round to $100M – MedCity News
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
When Vima Therapeutics launched last year to take its drug candidate into human testing, the lead indication was isolated dystonia,…
This is the Applied Clinical Trials Brief—your fast track to the latest insights shaping clinical operations and drug development. A…
Antwerp-based HealthTech startup Koios Care has closed a €1 million funding round to accelerate its efforts in transforming the monitoring…